From the Journals

Cochrane report: HPV vaccine proves its worth in adolescent, young adult women

Publish date: May 9, 2018

 

FROM THE COCHRANE LIBRARY


Several of the researchers received travel grants from GlaxoSmithKline or MSD-Sanofi-Pasteur.

SOURCE: Arbyn M et al. Cochrane Database Syst Rev. 2018. doi: 10.1002/14651858.CD009069.pub3.

Pages

Recommended Reading

Phase III trial: VZV protects auto-HCT patients
MDedge Hematology and Oncology
Parental reasons for HPV nonvaccination are shifting
MDedge Hematology and Oncology
Flu shots may spark immune adverse events in PD-1 blockade for NSCLC
MDedge Hematology and Oncology
Oral HPV infections sharply lower for vaccinated youth
MDedge Hematology and Oncology
Vaccination does not eliminate risk for meningococcal disease in eculizumab recipients
MDedge Hematology and Oncology
HPV vaccination rose after ACA implementation
MDedge Hematology and Oncology
Flu vaccine did not protect children with acute leukemia
MDedge Hematology and Oncology
Children with sickle cell anemia fall short on antibiotic adherence
MDedge Hematology and Oncology
High efficacy, no safety signals for herpes zoster vaccine post-HSCT
MDedge Hematology and Oncology
Too few Michigan children with SCD receive pneumococcal, meningococcal vaccines
MDedge Hematology and Oncology